• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Economy Socio Economic

Joe Biden and Jill billed to receive COVID-19 vaccine in public on Monday

Johnson Uche by Johnson Uche
December 20, 2020
in Socio Economic, Spotlight
Joe Biden and Jill billed to receive COVID-19 vaccine in public on Monday
Share on FacebookShare on TwitterShare on Linkedin

The President-elect of the United States, Joe Biden, and incoming First Lady, Jill Biden, will receive their first dose of the Covid-19 vaccine in public on Monday, the transition team confirmed.

The location of the event is yet to be officially announced, though would happen in Delaware and it is expected that the Bidens will also use the occasion to thank health care workers at the facility for all their efforts in saving lives.

READ: Up to 80% of Africans willing to take Covid-19 vaccine

MoreStories

Graduate

Top 10 most expensive MBA schools in Nigeria 

April 19, 2026
Scattered U.S. dollar bills."

FX reserves fall to $48.6bn, down $1.38bn in 5 weeks 

April 18, 2026

President-elect Biden has strongly expressed his desire to take the vaccine to ensure continuity of government and set a good example for the general public and also make a case to members of the public that the vaccines are safe.

According to the incoming White House Press Secretary, Jen Psaki, “It’s important to us, as he has stated many times, to send a clear message to the public that it’s safe.”

READ: CAC to register companies within 48 hours, approve business name same day

What you should know

The formal announcement of President Biden’s vaccination comes a day after one of his top officials, Rep. Cedric Richmond, tested positive for the virus, and just a few days after a member of the transition’s press pool was infected.

The Bidens will each receive a second dose of the Pfizer vaccine three weeks after the first, allowing them to be fully immunized before their scaled-down inauguration in late January.

Vice President-elect Kamala Harris and Second Gentleman Doug Emhoff will receive the shot the following week to avoid a situation in which all of the leaders of the incoming administration experience side effects at the same time.

READ: Lagos task force shuts down Cubana nightclub, other facilities for defying Sanwo-Olu’s order

What they are saying

Vice President Mike Pence, who received the vaccine recently alongside Second Lady Karen Pence and Surgeon General Jerome Adams, said

  • “We wanted to step forward and take this vaccine to assure the American people that while we cut red tape, we cut no corners.”

The Senate Majority Leader Mitch McConnell, who recently received the vaccine said,

  • “Just received the safe, effective COVID vaccine following continuity of government protocols. Vaccines are how we beat this virus. Now back to continue fighting for a rescue package including a lot more money for distribution, so more Americans can receive it as fast as possible.”

READ: Nigeria, others to receive first-ever HIV generic drug for babies in the first half of 2021

Bottom line

It is hoped that the televised vaccination will help calm distrust of a vaccine produced in record time.


Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: Covid-19 vaccineJill BidenJoe Biden
Johnson Uche

Johnson Uche

Johnson is a risk management professional and banker with unbridled passion for research and writing. He graduated top of the class with B.sc Statistics from the University of Nigeria and an MBA degree with specialization in Finance from Ambrose Alli University Ekpoma, with fellowships from the Association of Enterprise Risk management Professionals(FERP) and Institute of Credit and Collections management of Nigeria (FICCM). He is currently pursuing his PhD in Risk management in one of the top-rated universities in the UK.

Next Post
AstraZeneca suspends COVID-19 vaccine final stage trial over safety concerns, COVID-19: J&J starts vaccine trials on humans after success on monkeys

US health official says third Covid-19 vaccine could be out next month

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast

nairametrics




DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics